The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myeloma Summary CAR-T cell therapy for multiple myeloma significantly alters the patient’s existing T cell population. This Read More
Tags :Multiple
IST&I – Multiple PostDoc Positions job with MOHAMMED VI POLYTECHNIC UNIVERSITY | 398638 Times Higher Education Read more… Credits: Source DisclaimerRead More
Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary
Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma Summary Plasmapheresis, a procedure that filters blood, has shown promise in overcoming resistance to anti-BCMA immunotherapies for multiple Read More
London School of Economics and Political Science – Estates Division<br />Salary: £29,110 to £32,468 pa inclusive with potential to progress to £34,107 pa inclusive of London allowance Read more… Credits: jobs.ac.uk DisclaimerRead More
Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell
Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma Summary Daratumumab refractoriness significantly worsens outcomes after CAR T-cell therapy in patients with relapsed/refractory multiple myeloma. Studies show Read More
Multiple Sclerosis May be Related to Mitochondrial Dysfunction – New
Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the world. .. Summary Multiple sclerosis (MS) is a chronic inflammatory disease affecting approximately 2.3 million people globally. While the Read More
Clinical Curriculum Fellow (Fixed term, multiple positions) – Jobs in
University of Nottingham – Education Centre<br />Salary: £38,619 to £65,955 per annum, pro-rata depending on skills and experience. Salary progression beyond this scale is subject to performance. Read more… Credits: jobs.ac.uk DisclaimerRead More
Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene
Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma Summary Real-world data on idecabtagene vicleucel (ide-cel) and ciltacabtagene autoleucel (cilta-cel) CAR-T therapy for multiple Read More
Suppression of multiple mouse models of refractory malignancies by reprogramming
Suppression of multiple mouse models of refractory malignancies by reprogramming IL-18 ligand-receptor interaction Summary Researchers developed a novel immunotherapeutic strategy that reprograms the IL-18 pathway to combat refractory malignancies in mice. By engineering a “decoy” Read More
Mice with a diverse human T cell receptor repertoire selected on multiple HLA class I molecules Summary Mice were engineered to express a diverse range of human T cell receptors (TCRs) selected based on their Read More